Followers | 898 |
Posts | 148973 |
Boards Moderated | 0 |
Alias Born | 08/13/2010 |
Monday, October 04, 2021 6:45:01 PM
Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.
Recent XENE News
- Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 05/02/2024 08:01:00 PM
- Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 04/16/2024 12:30:00 PM
- Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/04/2024 08:01:00 PM
- Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days • GlobeNewswire Inc. • 03/12/2024 08:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 11:47:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:31:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:28:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:27:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 12:04:19 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 12:03:52 AM
- Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/05/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:10:54 PM
- Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/29/2024 09:01:00 PM
- Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:12:03 PM
- Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024 • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:41:00 PM
- Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 12/04/2023 09:16:53 PM
- Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023) • GlobeNewswire Inc. • 12/02/2023 05:01:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/30/2023 09:18:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/30/2023 09:15:24 PM
- Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering • GlobeNewswire Inc. • 11/30/2023 03:51:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/29/2023 10:05:41 PM
- Xenon Pharmaceuticals Announces Proposed Public Offering • GlobeNewswire Inc. • 11/29/2023 09:03:30 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM